Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)

China · Delayed Price · Currency is CNY

10.90

+0.29 (2.73%)

Jul 3, 2026, 3:04 PM CST

-13.77% (1Y)

Market Cap	3.65B -14.5%
Revenue (ttm)	1.27B -2.8%
Net Income	-49.74M
EPS	-0.14
Shares Out	334.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.15 (1.61%)
Ex-Dividend Date	May 30, 2025

Volume	16,767,186
Open	9.65
Previous Close	10.61
Day's Range	9.65 - 11.04
52-Week Range	9.02 - 18.96
Beta	-0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHE:002923

Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular; and pellets for excipient, antiulcerative, diabetes drug, anti-inflammatory, and anti-anginals. The company is also involved in the process development, quality research, and registration of chemical drugs. In addition, it provides branding services of drug products, as well as academic services. The comp... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1999

Employees 1,655

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002923

Full Company Profile

Financial Performance

In 2024, SHE:002923's revenue was 1.18 billion, a decrease of -8.48% compared to the previous year's 1.29 billion. Earnings were 39.88 million, a decrease of -40.38%.

Financial Statements